Your browser doesn't support javascript.
loading
Generation of Human Brain Organoids for Mitochondrial Disease Modeling.
Le, Stephanie; Petersilie, Laura; Inak, Gizem; Menacho-Pando, Carmen; Kafitz, Karl W; Rybak-Wolf, Agnieszka; Rajewsky, Nikolaus; Rose, Christine R; Prigione, Alessandro.
Afiliação
  • Le S; Department of General Pediatrics, Neonatology and Pediatric Cardiology, Duesseldorf University Hospital, Medical Faculty, Heinrich Heine University.
  • Petersilie L; Institute of Neurobiology, Heinrich Heine University.
  • Inak G; Department of General Pediatrics, Neonatology and Pediatric Cardiology, Duesseldorf University Hospital, Medical Faculty, Heinrich Heine University; Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai.
  • Menacho-Pando C; Department of General Pediatrics, Neonatology and Pediatric Cardiology, Duesseldorf University Hospital, Medical Faculty, Heinrich Heine University.
  • Kafitz KW; Institute of Neurobiology, Heinrich Heine University.
  • Rybak-Wolf A; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrueck Center for Molecular Medicine (MDC).
  • Rajewsky N; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrueck Center for Molecular Medicine (MDC).
  • Rose CR; Institute of Neurobiology, Heinrich Heine University.
  • Prigione A; Department of General Pediatrics, Neonatology and Pediatric Cardiology, Duesseldorf University Hospital, Medical Faculty, Heinrich Heine University; Max Delbrueck Center for Molecular Medicine (MDC); Alessandro.Prigione@hhu.de.
J Vis Exp ; (172)2021 06 21.
Article em En | MEDLINE | ID: mdl-34223837
ABSTRACT
Mitochondrial diseases represent the largest class of inborn errors of metabolism and are currently incurable. These diseases cause neurodevelopmental defects whose underlying mechanisms remain to be elucidated. A major roadblock is the lack of effective models recapitulating the early-onset neuronal impairment seen in the patients. Advances in the technology of induced pluripotent stem cells (iPSCs) enable the generation of three-dimensional (3D) brain organoids that can be used to investigate the impact of diseases on the development and organization of the nervous system. Researchers, including these authors, have recently introduced human brain organoids to model mitochondrial disorders. This paper reports a detailed protocol for the robust generation of human iPSC-derived brain organoids and their use in mitochondrial bioenergetic profiling and imaging analyses. These experiments will allow the use of brain organoids to investigate metabolic and developmental dysfunctions and may provide crucial information to dissect the neuronal pathology of mitochondrial diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Mitocondriais / Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Mitocondriais / Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2021 Tipo de documento: Article